EndocrineToday Profile Banner
Endocrine Today Profile
Endocrine Today

@EndocrineToday

Followers
15K
Following
9K
Media
1K
Statuses
23K

The content you need, when you need it.

Thorofare, NJ
Joined March 2009
Don't wanna be here? Send us removal request.
@EndocrineToday
Endocrine Today
21 hours
And that’s a wrap for #OW2025! We will see you next year at Washington D.C. ✈️✈️
0
0
2
@EndocrineToday
Endocrine Today
22 hours
Yesterday, the Trump administration struck deals with @EliLillyandCo & @novonordiskus to reduce U.S. GLP-1 prices for #obesity. The drugs will be offered at a discount for self-paying patients & those on Medicare/Medicaid. Read more on @GoHealio
Tweet card summary image
healio.com
Press Release President Donald J. Trump announced agreements with Eli Lilly and Novo Nordisk to reduce prices of available obesity drugs in the U.S..
0
0
0
@EndocrineToday
Endocrine Today
22 hours
💪Adults with #obesity who lost 30% or more body weight with CagriSema had more soft lean tissue than fat mass at the conclusion of the REDEFINE 1 trial. Find out other benefits the drug may provide in this @ObesityWeek news👇 @SubodhVermaMD @ObseitySociety #OW2025 @PBRCNews
0
0
1
@valent44355
Victor Renard
18 hours
PROBABLY THIS IS THE MOST UNDERVALUED COMPANY ON NASDAQ — ACCORDING TO WARREN BUFFETT-STYLE ANALYSIS When Warren Buffett said, “Price is what you pay, value is what you get,” he was describing companies exactly like NextNRG Inc ($NXXT). It’s a business producing real revenue,
2
9
99
@EndocrineToday
Endocrine Today
23 hours
It’s the final day of #OW2025 and just look at how many doctors participated in the coloring wall in the lobby! 🌈 Just because the meeting is ending doesn’t mean our news stops! Keep checking out our profile for updates from the meeting✍️ @ObesityWeek @GoHealio
0
0
4
@EndocrineToday
Endocrine Today
2 days
President Donald Trump announced deals with @EliLillyandCo and @novonordiskus to reduce prices of GLP-1s in the U.S., which could increase access for patients with #obesity. Read more on @GoHealio https://t.co/wK7EbZ6UFQ
Tweet card summary image
healio.com
Press Release President Donald J. Trump announced agreements with Eli Lilly and Novo Nordisk to reduce prices of available obesity drugs in the U.S..
0
3
3
@EndocrineToday
Endocrine Today
2 days
Really neat timeline near the entrance to the @ObesityWeek exhibit hall looking at #obesity research over the past 40 years! @ObesitySociety #OW2025
0
0
4
@capitalresearch
Capital Research Center
3 days
Federal investigators are taking a closer look at the Black Lives Matter Global Network Foundation’s finances. What could this probe mean for transparency, accountability, and the broader nonprofit sector?
19
30
194
@EndocrineToday
Endocrine Today
2 days
🔍 Want a go-to reference for every approved biosimilar in the U.S.? We've compiled the full list, even those not yet launched. 📘 Access it now in Biosimilars: A Healio® Guide for Clinicians: https://t.co/fOkg2SYRm3 #Biosimilars #FDAApproved #DrugList
0
0
0
@EndocrineToday
Endocrine Today
2 days
Other tools slow you down. Drug Lookup is built for the way clinicians work, fast, simple, reliable. Try it now: https://t.co/iCWDJISUXT   #Physicians #MedEd
0
0
0
@EndocrineToday
Endocrine Today
2 days
Day 3 live from Atlanta at #OW2025! Check out our profile for some highlights from the last two days of the meeting and keep your eyes peeled for what’s coming today! 👀 @ObesityWeek @GoHealio
0
0
2
@EndocrineToday
Endocrine Today
2 days
🎤 “Not only am I changing the weight of the patient sitting in front of me, but more importantly, I’m changing their overall health.” Dr. Deborah Horn discussed a wide range of cardiometabolic benefits associated with orforglipron at @ObesityWeek. https://t.co/jcYkorO9v0
Tweet card summary image
healio.com
ATLANTA — A once-daily oral nonpeptide GLP-1 conferred significant improvements in body weight, HbA1c and other cardiometabolic parameters for adults with obesity and type 2 diabetes, according to...
0
0
1
@EndocrineToday
Endocrine Today
3 days
🚨 At @ObesityWeek, researchers presented the first detailed look at results from the ATTAIN-2 phase 3 trial, which showed an oral #GLP1 can lower body weight and HbA1c for adults with #obesity and type 2 #diabetes. Read the full story ⬇️ https://t.co/jcYkorO9v0 #OW2025
Tweet card summary image
healio.com
ATLANTA — A once-daily oral nonpeptide GLP-1 conferred significant improvements in body weight, HbA1c and other cardiometabolic parameters for adults with obesity and type 2 diabetes, according to...
0
0
1
@EndocrineToday
Endocrine Today
3 days
As always, Healio takes time out of our #OW2025 coverage to meet and greet the doggies available for adoption in the exhibit hall! These pups are open to their new homes, so if you want a new furry friend, stop by!
0
0
0
@blkboxeconomics
Edward Lear
14 hours
A stock-pumping White House unable, to mask such a market unstable, now no chance in hiding, toward panic we’re sliding, this Golden Age story pure fable.
1
0
19
@EndocrineToday
Endocrine Today
3 days
Getting seated in the auditorium for the Key Lecturer talk with @ArianaMChao 👏 Is lifestyle change a thing of the past now that effective #obesity medications have become so widespread? #OW2025 @ObesityWeek
0
0
3
@EndocrineToday
Endocrine Today
3 days
Day 2 in Atlanta for #OW2025! The sun is shining, folks are relaxing in the park, and the Healio team is ready to bring you some #obesity news ☀️
0
0
1
@EndocrineToday
Endocrine Today
4 days
Dr. Daniel Bessesen of University of Colorado kicks off a panel discussion on #obesity as a chronic disease at @ObesityWeek. @ObesitySociety #OW2025
0
1
9
@EndocrineToday
Endocrine Today
4 days
🎤 Dr. Marc-Andre Cornier, president of the @ObesitySociety, discusses this year’s theme of @ObesityWeek: “#Obesity is a serious chronic disease.” #OW2025
0
0
0
@scottdclary
Scott D. Clary
6 hours
Your standards should make people uncomfortable. If everyone is comfortable with your expectations, they’re too low. High standards create friction. Embrace the friction. It filters out the wrong people and attracts the right ones.
0
0
52